The three AD animal models used recapitulate amyloid pathology either through APP overexpression (AppSweLon) or knock-in (AppNL-F and AppNL-G-F) of FAD APP mutations known to increase the Aβ42/Aβ40 ratio. This evidence concerns the gene APP and Alzheimer disease.